McKesson Corporation (NYSE:MCK) Files An 8-K Regulation FD Disclosure
Item7.01
| Regulation FD Disclosure. |
On June28, 2017, in connection with its Investor Day in Boston,
Massachusetts, McKesson Corporation (the Company) issued a press
release reaffirming its earnings guidance for the fiscal year
ending March31, 2018. A copy of the Companys press release is
attached hereto as Exhibit 99.1.
On June28, 2017, the Company posted to its website supplemental
recast financial information for fiscal years ended March31, 2011
through March31, 2016 for its amended definition of Adjusted
Earnings (Non-GAAP). From the main page of the Companys website,
the posted material can be located under the Investors tab.
The information contained in this Form 8-K, including Exhibits
99.1 and 99.2, is furnished to the Securities and Exchange
Commission (the Commission), but shall not be deemed filed with
the Commission for purposes of Section18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act), or
incorporated by reference in any filing under the Securities Act
of 1933, as amended, or the Exchange Act except as shall be
expressly set forth by specific reference in such a filing.
Item9.01 |
Financial Statements and Exhibits. |
(d) |
Exhibits. |
|
|
|
|
| 99.1 | Press release issued by the Company dated June28, 2017. | |
| 99.2 |
Supplemental recast financial information as posted to the Companys website on June28, 2017. |
MCKESSON CORP ExhibitEX-99.1 2 d418943dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 McKESSON REAFFIRMS FISCAL 2018 GUIDANCE SAN FRANCISCO,…To view the full exhibit click here About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.
